Acesulfame K

Acesulfame potassium (acesulfame K, E950) is a synthetic, calorie-free sweetener approximately 200 times sweeter than sucrose, first developed by Hoechst chemist Karl Clauss in 1967. Its chemical structure — a six-membered oxathiazinone ring with a potassium sulphonate group — is completely stable under pasteurisation, baking, and the acidic conditions of carbonated beverages, making it one of the most heat- and acid-stable high-intensity sweeteners available. It is frequently blended with aspartame (E951) or sucralose (E955) to improve flavour profile, as acesulfame K alone has a bitter-metallic aftertaste at higher concentrations that synergistic blending mitigates. Applications include soft drinks, desserts, confectionery, chewing gum, and tabletop sweeteners.

JECFA established an ADI of 15 mg/kg body weight per day for acesulfame K (evaluated 2006), and the European Food Safety Authority confirmed the same 15 mg/kg ADI in its 2000 opinion. This agreement between JECFA and EFSA is notable given their occasional divergence on other additives. The ADI was derived from long-term carcinogenicity and reproductive toxicity studies in rats and mice, with the critical study showing a NOAEL of 2,000 mg/kg/day and an uncertainty factor of 100 applied. Estimated dietary exposure from food additive use is generally well below the ADI except in very high-consuming individuals drinking multiple servings of acesulfame K-sweetened diet beverages daily.

Acesulfame K is authorised under EU Regulation (EC) No 1333/2008 and US FDA 21 CFR §172.800 with specific maximum permitted levels in designated food categories. Unlike aspartame, it is stable under all food processing conditions and carries no phenylketonuria (PKU) warning requirement. Emerging research has examined potential effects on glucose metabolism and gut microbiota from high doses in animal models, but human clinical evidence at achievable dietary exposures does not support adverse metabolic effects. Several beverage manufacturers have moved away from acesulfame K in consumer-facing reformulations for clean-label reasons, despite its robust safety record and regulatory clearance in over 100 countries.